Cresco Labs Inc. (CRLBF)
(Delayed Data from OTC)
$1.77 USD
-0.05 (-2.75%)
Updated Jun 7, 2024 04:00 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Cresco Labs Inc. [CRLBF]
Reports for Purchase
Showing records 21 - 40 ( 129 total )
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: State Led Growth Story to Continue in 2024
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Yearly ReHash: Biggest Developments in Cannabis in 2023
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: New York Set to Expand Adult-use in 2024
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Green Wednesday - Cannabis Industry''s Black Friday
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Company: Cresco Labs Inc.
Industry: Medical - Products
3Q23 Beat, Lean Core Ops Improves Margins and Cash Flow Without Growth
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Strong Q323 Print. Still Relatively Few Immediate Growth Drivers
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Cresco Labs Inc.
Industry: Medical - Products
Company: Cresco Labs Inc.
Industry: Medical - Products
Cannabis Industry Update: Ohio Becomes 24th Adult-Use State
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Cresco Labs Inc.
Industry: Medical - Products
Consumer - Weekly ReHash: 3Q23 Earnings Week I
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Cannabis Industry Update: 3Q23 Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Ohio State Primer, Likely Positive Ballot Vote November 7th
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Industry 3Q23 Insight
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Cannabis Industry Update: 3Q23 Performance Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Remains a State Led Growth Story
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Equitization of Debt to Rebalance Balance Seets
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Valuation Expectations Framework
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis Returns Sustainable on LT Catalyst Unlocks
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: An Update on Cannabis Capital Raising
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S